MedTech Dive April 18, 2024
Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.
Dive Brief:
- Scientific instruments maker Bruker will pay about $392.6 million in cash to acquire most of the assets of Nanostring, a provider of research tools for spatial biology and gene expression, Nanostring said Wednesday.
- The sale will conclude Nanostring’s bankruptcy proceeding and restructuring process, the Seattle-based company said. When it filed for Chapter 11 protection in February, Nanostring disclosed it had received multiple early indications of interest from possible acquirers.
- Bruker’s acquisition, which includes the assumption of certain liabilities, will allow Nanostring’s business operations and product development initiatives to continue for customers and substantially all of the company’s employees,...
Today's Sponsors
Today's Sponsor